Glenmark, Teva Say DOJ 'Rewriting' Price-Fixing Indictment
The U.S. Department of Justice's pre-trial feud with Glenmark and Teva continued to escalate Friday in Pennsylvania federal court with the generic drugmakers accusing the DOJ of trying to add assertions...To view the full article, register now.
Already a subscriber? Click here to view full article